State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy/ School of Modern Chinese Medicine Industry, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, P. R. China.
Huachiew TCM Hospital, Bangkok 10100, Thailand.
Am J Chin Med. 2024;52(2):387-415. doi: 10.1142/S0192415X24500162. Epub 2024 Mar 16.
Turmeric is widely used worldwide, and there are many examples of its use in treating hepatobiliary diseases. The gut-liver axis is a bidirectional relationship between gut microorganisms and the liver that is closely related to the pathogenesis of hepatobiliary diseases. This review systematically summarizes the components of turmeric. It links the studies on turmeric affecting gut microorganisms to its effects on liver and biliary diseases to explain the potential mechanism of turmeric's regulation of the gut-liver axis. Besides, ethnopharmacology, phytochemicals, and clinical adverse events associated with turmeric have been researched. Furthermore, turmeric is a safe agent with good clinical efficacy and without apparent toxicity at a certain amount. By summarizing the influence of turmeric on the liver by regulating the gut-liver axis, especially the gut microbiota, it provides a preclinical basis for using turmeric as a safe and effective therapeutic agent for the prevention and treatment of hepatobiliary diseases based on the gut-liver axis. However, more efforts should be made to exploit its clinical application further.
姜黄在世界范围内广泛应用,有许多用其治疗肝胆疾病的例子。肠-肝轴是肠道微生物群和肝脏之间的双向关系,与肝胆疾病的发病机制密切相关。本综述系统总结了姜黄的成分。它将姜黄影响肠道微生物群的研究与其对肝脏和胆道疾病的影响联系起来,以解释姜黄调节肠-肝轴的潜在机制。此外,还研究了姜黄的民族药理学、植物化学和相关的临床不良事件。此外,姜黄是一种安全的药物,在一定剂量下具有良好的临床疗效,且无明显毒性。通过总结姜黄通过调节肠-肝轴,特别是肠道微生物群对肝脏的影响,为将姜黄作为一种安全有效的治疗肝胆疾病的药物提供了临床前依据。然而,还需要进一步努力以进一步开发其临床应用。